Litigation Details for Alkermes Pharma Ireland Limited v. Luye Pharma Group Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Alkermes Pharma Ireland Limited v. Luye Pharma Group Ltd. (D. Del. 2019)
| Docket | 1:19-cv-01340 | Date Filed | 2019-07-17 |
| Court | District Court, D. Delaware | Date Terminated | 2019-12-03 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | LUYE PHARMA (USA) LTD. | ||
| Patents | 6,667,061 | ||
| Attorneys | Scott A. Cunning , II | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Alkermes Pharma Ireland Limited v. Luye Pharma Group Ltd.
The small molecule drugs covered by the patent cited in this case are ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , and ⤷ Start Trial .
Details for Alkermes Pharma Ireland Limited v. Luye Pharma Group Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-07-17 | External link to document | |||
| 2019-07-17 | 1 | Complaint | infringement of United States Patent No. 6,667,061 (“the ’061 patent”) under the Patent Laws of the United States…infringed one or more claims of United States Patent No. 6,667,061 by submitting NDA No. 212849 seeking FDA… before the expiration of United States Patent No. 6,667,061 including any extensions and additional…infringe one or more claims of United States Patent No. 6,667,061 under 35 U.S.C. §§ 271(a), (b), and/or (…day after the expiration of United States Patent No. 6,667,061, inclusive of any extensions or additional | External link to document |
| 2019-07-17 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,667,061 B2. (sam) (Entered:…2019 3 December 2019 1:19-cv-01340 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2019-07-17 | 58 | Stipulation of Dismissal | Defendants”) for infringement of U.S. Patent No. 6,667,061 (the “Patent” and such action, the “Litigation”…DISMISSAL WHEREAS, this action for patent infringement has been brought by Plaintiffs Alkermes…2019 3 December 2019 1:19-cv-01340 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
